Association between plasma paroxetine concentration and changes in plasma brain-derived neurotrophic factor levels in patients with major depressive disorder

Human Psychopharmacology

Volumn 26, Issue 3, 2011, Pages 194-200

  Yasui Furukori, Norio ^a   Tsuchimine, Shoko ^a   Nakagami, Taku ^a   Fujii, Akira ^a   Sato, Yasushi ^a   Tomita, Tetsu ^a   Yoshizawa, Kaori ^a   Inoue, Yoshimasa ^b   Kaneko, Sunao ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b MP Techno Pharma   (Japan)

Author keywords

Major depressive disorder; Paroxetine concentration; Plasma BDNF

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; PAROXETINE;

ADULT; AGED; ARTICLE; DRUG BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; PAROXETINE; YOUNG ADULT;

EID: 80051802478     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.1192     Document Type: Article

References (54)

1. APA. 2000. American Psychiatric Association, Diagnostic Criteria from DSM-IV-TR. American Psychiatric Association: Washington, DC.
2. Aydemir O, Deveci A, Taneli F. 2005. The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study. Prog Neuropsychopharmacol Biol Psychiatry 29: 261-265. (Pubitemid 40202912)
3. Aydemir C, Yalcin ES, Aksaray S, et al 2006. Brain-derived neurotrophic factor (BDNF) changes in the serum of depressed women. Prog Neuropsychopharmacol Biol Psychiatry 30: 1256-1260. (Pubitemid 44216065)
4. Begliuomini S, Casarosa E, Pluchino N, et al. 2007. Influence of endogenous and exogenous sex hormones on plasma brain-derived neurotrophic factor. Hum Reprod 22: 995-1002.
5. Bramham CR, Messaoudi E. 2005. BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis. Prog Neurobiol 76: 99-125. (Pubitemid 41242884)
6. Brunoni AR, Lopes M, Fregni F. 2008. A systematic review and metaanalysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int J Neuropsychopharmacol 11: 1169-1180.
7. Bocchio-Chiavetto L, Bagnardi V, Zanardini R, et al. 2010. Serum and plasma BDNF levels in major depression: a replication study and metaanalyses. World J Biol Psychiatry 11: 763-773.
8. Cubeddu A, Giannini A, Bucci F, et al. 2010. Paroxetine increases brainderived neurotrophic factor in postmenopausal women. Menopause 17: 338-343.
9. D'Sa C, Duman RS. 2002. Antidepressants and neuroplasticity. Bipolar Disord 4: 1831-1894.
10. Duman RS. 2004. Role of neurotrophic factors in etiology and treatment of mood disorders. Neuromolecular Med 5: 11-25. (Pubitemid 38391953)
11. Elfving B, Plougmann PH, Wegener G. 2010. Detection of brain-derived neurotrophic factor (BDNF) in rat blood and brain preparations using ELISA: pitfalls and solutions. J Neurosci Meth 187: 73-77.
12. Ferrer I, Ballabriga J, Martí E, Pérez E, Alberch J, Arenas E. 1998. BDNF up-regulates TrkB protein and prevents the death of CA1 neurons following transient forebrain ischemia. Brain Pathol 8: 253-261. (Pubitemid 28186063)
13. Furutani K, Okubo Y, Kakizawa S, Iino M. 2006. Postsynaptic inositol 1,4,5-trisphosphate signaling maintains presynaptic function of parallel fiber-Purkinje cell synapses via BDNF. Proc Natl Acad Sci USA 103: 8528-8533. (Pubitemid 43838489)
14. Gervasoni N, Aubry JM, Bondolfi G, et al. 2005. Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode. Neuropsychobiology 51: 234-238. (Pubitemid 40976406)
15. Gilles M, Deuschle M, Kellner S, et al. 2005. Paroxetine serum concentrations in depressed patients and response to treatment. Pharmacopsychiatry 38: 118-121. (Pubitemid 40965963)
16. Gilmor ML, Owens MJ, Nemeroff CB. 2002. Inhibition of norepinephrine uptake in patients with major depression treated with paroxetine. Am J Psychiatry 159: 1702-1710.
17. Gonul AS, Akdeniz F, Taneli F, Donat O, Eker C, Vahip S. 2005. Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. Eur Arch Psychiatry Clin Neurosci 255: 381-386. (Pubitemid 43029827)
18. Huang TL, Lee CT, Liu YL. 2008. Serum brain-derived neurotrophic factor levels in patients with major depression: effects of antidepressants. J Psychiatr Res 42: 521-525.
19. Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM. 2002a. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 109: 143-148. (Pubitemid 34258493)
20. Karege F, Schwald M, Cisse M. 2002b. Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci Lett 328: 261-264. (Pubitemid 34876661)
21. Karege F, Bondolfi G, Gervasoni N, Schwald M, Aubry JM, Bertschy G. 2005. Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol Psychiatry 257: 1068-1072. (Pubitemid 40613035)
22. Knusel B, Winslow JW, Rosenthal A, et al. 1991. Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3. Proc Natl Acad Sci USA 88: 961-965. (Pubitemid 21916144)
23. Komulainen P, Pedersen M, Hänninen T, et al. 2008. BDNF is a novel marker of cognitive function in ageing women: the DR's EXTRA Study. Neurobiol Learn Mem 90: 596-603.
24. Lee HY, Kim YK. 2008. Plasma brain-derived neurotrophic factor as a peripheral marker for the action mechanism of antidepressants. Neuropsychobiology 57: 194-199.
25. Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K. 1987. The UKU side effect rating scale.Anew comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand 76(Suppl. s334): 1-100. (Pubitemid 17115352)
26. Lommatzsch M, Zingler D, Schuhbaeck K, et al. 2005. The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol Aging 26: 115-123. (Pubitemid 39600596)
27. Mannari C, Origlia N, Scatena A, et al. 2008. BDNF level in the rat prefrontal cortex increases following chronic but not acute treatment with duloxetine, a dual acting inhibitor of noradrenaline and serotonin re-uptake. Cell Mol Neurobiol 28: 457-468.
28. Matrisciano F, Bonaccorso S, Ricciardi A, et al. 2009. Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine. J Psychiatr Res 43: 247-254.
29. McGrath PJ, Stewart JW, Quitkin FM, et al. 2006. Predictors of relapse in a prospective study of fluoxetine treatment of major depression. Am J Psychiatry 163: 1542-1548. (Pubitemid 44465753)
30. Meyer JH, Wilson AA, Sagrati S, et al. 2004. Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C] DASBpositron emission tomography study. AmJ Psychiatry 161: 826-835. (Pubitemid 38625335)
31. Montgomery SA, Åsberg M. 1979. A new depression scale designed to be sensitive to change. Br J Psychiatry 134: 382-389. (Pubitemid 9136500)
32. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM. 2002. Neurobiology of depression. Neuron 34: 13-25. (Pubitemid 34270695)
33. Nibuya M, Morinobu S, Duman RS. 1995. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15: 7539-7547.
34. Pettit JW, Lewinsohn PM, Joiner TE, Jr. 2006. Propagation of major depressive disorder: relationship between first episode symptoms and recurrence. Psychiatry Res 141: 27127-27128.
35. Piccinni A, Marazziti D, Catena M, et al. 2008a. Plasma and serum brainderived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments. J Affect Disord 105: 279-283. (Pubitemid 350245688)
36. Piccinni A, Marazziti D, Del Debbio A, et al. 2008b. Diurnal variation of plasma brain-derived neurotrophic factor (BDNF) in humans: an analysis of sex differences. Chronobiol Int 25: 819-826.
37. Pinto-Meza A, Usall J, Serrano-Blanco A, Suárez D, Haro JM. 2006. Gender differences in response to antidepressant treatment prescribed in primary care. Does menopause make a difference? J Affect Disord 93: 53-60. (Pubitemid 43833246)
38. Sato K, Akaishi T,Matsuki N, Ohno Y, Nakazawa K. 2007. β-Estradiol induces synaptogenesis in the hippocampus by enhancing brain-derived neurotrophic factor release from dentate gyrus granule cells. Brain Res 1150: 108-120. (Pubitemid 46702123)
39. Segal RA, Pomeroy SL, Stiles CD. 1995. Axonal growth and fasciculation linked to differential expression of BDNF and NT3 receptors in developing cerebellar granule cells. J Neurosci 15: 4970-4981.
40. Segal RA, Rua L, Schwartz P. 1997. Neurotrophins and programmed cell death during cerebellar development. Adv Neurol 72: 79-86.
41. Sen S, Duman R, Sanacora G. 2008. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry 64: 527-532.
42. Shen L, Figurov A, Lu B. 1997. Recent progress in studies of neurotrophic factors and their clinical implications. J Mol Med 75: 637-644. (Pubitemid 27412705)
43. Shi Y, You J, Yuan Y, Zhang X, Li H, Hou G. 2010. Plasma BDNF and tPA are associated with late-onset geriatric depression. Psychiatry Clin Neurosci 64: 249-254.
44. Shimizu E, Hashimoto K, Okamura N, et al. 2003. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 54: 70-75. (Pubitemid 36776725)
45. Singh M, Meyer EM, Simpkins JW. 1995. The effect of ovariectomy and estradiol replacement on brain-derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal brain regions of female Sprague-Dawley rats. Endocrinology 136: 2320-2324.
46. Sohrabji F, Miranda RC, Toran-Allerand CD. 1995. Identification of a putative estrogen response element in the gene encoding brain-derived neurotrophic factor. Proc Natl Acad Sci USA 92: 11110-11114.
47. Takahashi N, Tomita K, Higuchi T, Inada T. 2004. The inter-rater reliability of the Japanese version of the Montgomery-Asberg depression rating scale (MADRS) using a structured interview guide forMADRS(SIGMA). Hum Psychopharmacol 19: 187-192. (Pubitemid 38514830)
48. Terracciano A, Martin B, Ansari D, et al. 2010. Plasma BDNF concentration, Val66Met genetic variant and depression-related personality traits. Genes Brain Behav 9: 512-518.
49. Yamada K, Mizuno M, Nabeshima T. 2002. Role for brain-derived neurotrophic factor in learning and memory. Life Sci 70: 735-744. (Pubitemid 34075562)
50. Yasui-Furukori N, Saito M, Inoue Y, et al. 2007a. Terbinafine increases the plasma concentration of paroxetine after a single oral administration of paroxetine in healthy subjects. Eur J Clin Pharmacol 63: 51-56. (Pubitemid 46025473)
51. Yasui-Furukori N, Saito M, Niioka T, Inoue Y, Sato Y, Kaneko S. 2007b. Effect of itraconazole on pharmacokinetics of paroxetine: the role of gut transporters. Ther Drug Monit 29: 45-48. (Pubitemid 46279875)
52. Yoshimura R, Mitoma M, Sugita A, et al. 2007. Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 31: 1034-1037. (Pubitemid 46824019)
53. Yoshimura R, Ikenouchi-Sugita A, Hori H, et al. 2010. Adding a low dose atypical antipsychotic drug to an antidepressant induced a rapid increase of plasma brain-derived neurotrophic factor levels in patients with treatment-resistant depression. Prog Neuropsychopharmacol Biol Psychiatry 34: 308-312.
54. Zhou J, Zhang H, Cohen RS, Pandey SC. 2005. Effects of estrogen treatment on expression of brain-derived neurotrophic factor and cAMP response element-binding protein expression and phosphorylation in rat amygdaloid and hippocampal structures. Neuroendocrinology 81: 294-310. (Pubitemid 41527861)